For many individuals and couples navigating the complexities of infertility, the journey through In Vitro Fertilization (IVF) is filled with hope and anxiety. One of the most significant advancements in reproductive medicine is Preimplantation Genetic Testing (PGT). This technology allows clinicians to screen embryos for genetic abnormalities before they’re transferred to the uterus, significantly increasing the odds of a healthy pregnancy and reducing the risk of miscarriage.
- PGT is a genetic screening process performed on embryos created via IVF.
- Testing typically occurs at the blastocyst stage, around the fifth or sixth day after fertilization.
- There are three main types of PGT: PGT-A (aneuploidy), PGT-M (monogenic), and PGT-SR (structural rearrangements).
- The primary goals are to improve pregnancy success rates and prevent the transmission of heritable genetic disorders.
What is Preimplantation Genetic Testing (PGT)?
Preimplantation Genetic Testing, often referred to as embryo screening, is a procedure used alongside IVF to analyze the genetic makeup of embryos. Unlike prenatal testing, which happens during pregnancy, PGT occurs before implantation. By identifying which embryos are chromosomally “normal” (euploid) and which have abnormalities (aneuploid), doctors can select the embryo with the highest potential for a successful, healthy birth.
The Three Main Types of PGT
Not all genetic testing is the same. Depending on the patient’s medical history and goals, a fertility specialist will recommend one of three specific types of screening:
1. PGT-A (Aneuploidy Screening)
PGT-A is the most common form of testing. It screens for aneuploidy, which is an abnormal number of chromosomes. For example, an embryo with an extra copy of chromosome 21 would lead to Down syndrome. PGT-A doesn’t look for specific inherited diseases but rather ensures the embryo has the correct total number of chromosomes (46). This is particularly beneficial for women of advanced maternal age, as the risk of chromosomal errors increases over time.
2. PGT-M (Monogenic/Single-Gene Screening)
PGT-M is used when parents are known carriers of a specific genetic mutation. This targeted test looks for a single-gene disorder, such as cystic fibrosis, sickle cell anemia, or Huntington’s disease. By using PGT-M, parents can ensure they don’t pass a known hereditary condition to their children.
3. PGT-SR (Structural Rearrangements)
PGT-SR is designed for individuals who have a balanced translocation or inversion in their chromosomes. While the parent may be healthy, these structural rearrangements can lead to embryos with missing or extra pieces of genetic material, often resulting in recurrent miscarriages or infertility.
The Process: How PGT Works
The integration of PGT into an IVF cycle requires precision and timing. The process generally follows these steps:
- Egg Retrieval and Fertilization: Eggs are harvested and fertilized with sperm in a laboratory setting.
- Embryo Culture: The resulting embryos are grown in a controlled environment.
- The Biopsy (Day 5 or 6): Testing is typically performed around the fifth day after fertilization, when the embryo reaches the blastocyst stage. At this point, the embryo has developed a layer of cells called the trophectoderm, which eventually becomes the placenta. A few cells are carefully removed from this layer without harming the inner cell mass that becomes the fetus.
- Genetic Analysis: The biopsied cells are sent to a genetics lab for analysis while the embryos are cryopreserved (frozen).
- Transfer: Once the results are available, a genetically healthy embryo is selected and transferred into the uterus.
Who Should Consider PGT?
While PGT is an option for many, it’s especially recommended for specific groups. According to guidelines from the American Society for Reproductive Medicine (ASRM), those who may benefit most include:
- Women over 35: Because egg quality declines with age, the rate of chromosomal abnormalities increases.
- Individuals with recurrent pregnancy loss: Frequent miscarriages are often caused by chromosomal imbalances in the embryo.
- Known genetic carriers: Couples who carry a mutation for a serious heritable disease.
- Patients with a history of multiple failed IVF cycles: PGT can help determine if previous failures were due to embryo genetics.
Benefits and Considerations
PGT offers several advantages, but it’s not without its trade-offs. It’s important to weigh the pros and cons with a healthcare provider.
| Benefits | Considerations |
|---|---|
| Higher pregnancy success rates per transfer | Additional financial cost |
| Reduced risk of miscarriage | Requirement for embryo freezing (no “fresh” transfer) |
| Prevention of hereditary diseases | Small risk of damage to the embryo during biopsy |
| Lower likelihood of multiple births (by transferring one healthy embryo) | Possibility of having no healthy embryos to transfer |
Frequently Asked Questions
Does PGT guarantee a healthy baby?
No. While PGT significantly reduces the risk of chromosomal abnormalities and specific genetic diseases, it cannot screen for every possible birth defect or developmental issue. Prenatal screening during pregnancy is still recommended.
Is PGT safe for the embryo?
The biopsy is performed on the trophectoderm (the future placenta), not the inner cell mass. Research shows that the biopsy process has a remarkably low impact on the overall viability of the embryo and does not significantly increase the risk of birth defects.
Can PGT determine the sex of the baby?
Yes. Because PGT-A looks at the sex chromosomes (X and Y), it can identify the biological sex of the embryo. In many regions, this information is used primarily for medical reasons or as part of the genetic screening process.
Looking Ahead
The field of reproductive genetics is evolving rapidly. We’re moving toward more non-invasive methods, such as analyzing cell-free DNA in the culture medium surrounding the embryo, which could eventually eliminate the need for a physical biopsy. For now, PGT remains a gold-standard tool in the IVF toolkit, offering families a clearer path toward a healthy pregnancy and peace of mind.